Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania and Medidata AI.
Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help to control inflammation-related conditions.
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new Cornell-led study identifies potential therapies that might one day reverse these unhealthy shifts.
Cornell's newest interdisciplinary EEG lab could help faculty make breakthroughs in fields ranging from psychology to neurology to artificial intelligence.
Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
A new study that tracks how many asthma-related emergency room visits result from pollen in metropolitan areas across Central Texas highlights the importance of knowing local plants and the need for developing science-based pollen forecasts.
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Eleven teaching faculty from across the university have been awarded Cornell’s highest honors for graduate and undergraduate teaching, Interim President Michael I. Kotlikoff announced Oct. 22.